Cargando…
Simulating therapeutic drug monitoring results for dose individualisation to maintain investigator blinding in a randomised controlled trial
BACKGROUND: Therapeutic drug monitoring (TDM) is essential practice when dosing drugs with a narrow therapeutic index in order to achieve a plasma drug concentration within a narrow target range above the efficacy concentration but below the toxicity concentration. However, TDM with dose individuali...
Autores principales: | Lesosky, Maia, Joska, John, Decloedt, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463313/ https://www.ncbi.nlm.nih.gov/pubmed/28592271 http://dx.doi.org/10.1186/s13063-017-1992-6 |
Ejemplares similares
-
Renal safety of lithium in HIV-infected patients established on tenofovir disoproxil fumarate containing antiretroviral therapy: analysis from a randomized placebo-controlled trial
por: Decloedt, Eric H., et al.
Publicado: (2017) -
Blood and cerebrospinal fluid biomarker changes in patients with HIV-associated neurocognitive impairment treated with lithium: analysis from a randomised placebo-controlled trial
por: Thela, Lindokuhle, et al.
Publicado: (2023) -
Moderate to severe HIV-associated neurocognitive impairment: A randomized placebo-controlled trial of lithium
por: Decloedt, Eric H., et al.
Publicado: (2016) -
Employing the therapeutic operating characteristic (TOC) graph for individualised dose prescription
por: Hoffmann, Aswin L, et al.
Publicado: (2013) -
Investigating causal mechanisms in randomised controlled trials
por: Lee, Hopin, et al.
Publicado: (2019)